Hot Life Science Investor Mandate 1: Venture Arm of Large Organization to Invest in at Least Two New Firms in 2013 – February 20, 2013

20 Feb

The venture arm of a larger organization based in the Western US is currently looking for new companies in the life science space to invest in, and anticipates on investing in at least two new firms this year. The firm has an evergreen structure, meaning that funds come directly from its parent organization, and can be deployed as needed. The arm was allotted around $5 million in 2013 for new investments, and typically makes equity investments ranging from $500,000 to $3 million.

The firm is currently looking for companies in the biotech therapeutics space, and are especially interested in companies that are developing therapeutics that treat diseases that fall within the realm of neuromuscular diseases, of which there about 40.

They will invest in firms anywhere in the world, but primarily only in pre-revenue companies. That being said, they have no criteria in terms of revenue or EBITDA. The firm will invest in companies that have products ranging from proof of concept in phase I to phase III.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: